Introduction
U.J. McMahan, Renée K. Margolis, David C. Turner, Gregory C. Sephel, Rebecca Tuttle, John L. Bixby, Sherry L. Rogers, Hynda K. Kleinman(National Institutes of Health), Matthias Chiquet, Irene V. Pech, Naomi Kleitman, Michael J. Ignatius(Gladstone Institutes), Mary Bartlett Bunge, William Diller Matthew, Paul C. Letourneau(University of Minnesota), Bruce G. Wallace, Helen M. Buettner, Kevin J. Tomaselli, Beth A. Burrous, Richard U. Margolis, Alfred Sandrock(Biogen (United States)), Randall N. Pittman(University of Pennsylvania), Richard P. Bunge, Deborah E. Hall(University of California, San Francisco), Louis F. Reichardt(University of California, San Francisco), Karla M. Neugebauer(Yale University), Leonard A. Flier, Andy C. Dean
Cited by 0
Related Papers
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease
|The Journal of Prevention of Alzheimer s Disease|2022|1.3k
Expression of apolipoprotein E during nerve degeneration and regeneration.
|Proceedings of the National Academy of Sciences|1986|568